2,4-Difluoro-α-(1H-1,2,4-triazolyl)acetophenone (DFTA)

2,4-Difluoro-α-(1H-1,2,4-triazolyl)acetophenone (DFTA) chemical structure

2,4-Difluoro-α-(1H-1,2,4-triazolyl)acetophenone (DFTA)

CAS Number:86404-63-9
End Use:Fluconazole & Voriconazole
COA:Available
DMF:Available
Description
Name of Product: 2,4-Difluoro-α-(1H-1,2,4-triazolyl)acetophenone (DFTA)
Form: Powder
End Use: Fluconazole & Voriconazole
CAS Number: 86404-63-9

Holiness Pharmaceutical is a trusted and leading pharmaceutical intermediate exporter, supplier and manufacturer of 2,4-Difluoro-α-(1H-1,2,4-triazolyl)acetophenone (DFTA), a key azole antifungal advanced intermediate used in the synthesis of Fluconazole and Voriconazole APIs. We supply high-purity intermediates to pharmaceutical manufacturers across 40+ international markets, supporting regulated and semi-regulated API production.

Globally, Holiness Pharmaceutical is recognized among reliable azole intermediate manufacturers, offering consistent chemical purity, controlled fluorinated substitution, and stable reactivity essential for downstream antifungal synthesis. Our expertise in triazole and fluorinated aromatic chemistry positions us as a dependable pharmaceutical intermediate exporter from India.

Our advanced intermediate manufacturing facilities operate in strict compliance with international quality standards including:
DCGI, WHO-GMP aligned, and cGMP guidelines,
ensuring validated synthetic routes, batch-to-batch consistency, traceability, and comprehensive quality documentation.

We export DFTA and other high-value pharmaceutical intermediates from India to Asia, Africa, Europe, the Middle East, North America, South America, and CIS regions, supporting API manufacturers focused on antifungal therapies.

Holiness Pharmaceutical Ltd. is a fully integrated organization engaged in the complete lifecycle of intermediates — including route scouting, triazole chemistry, process optimization, commercial-scale manufacturing, and global supply of advanced intermediates for regulated APIs.

Holiness Pharmaceutical has established a strong presence in many countries including:
United States, Canada, United Kingdom, Germany, France, Netherlands, Italy, Spain, Australia, New Zealand, Slovakia, Estonia, Belarus, Ukraine, Iceland, Kazakhstan, Uzbekistan, Turkmenistan, Tajikistan, Kyrgyzstan, Georgia, Russia, Yemen, Saudi Arabia, UAE, Qatar, Kuwait, Oman, Bahrain, Turkey, Senegal, Ethiopia, Eswatini, Cameroon, Zambia, Mozambique, Angola, Zimbabwe, Malawi, Seychelles, South Africa, Nigeria, Kenya, Tanzania, Ghana, Egypt, Panama, Costa Rica, El Salvador, Mexico, Brazil, Argentina, Chile, Peru, Colombia, Afghanistan, Bhutan, Cambodia, Vietnam, Indonesia, Philippines, Malaysia, Thailand, South Korea, Japan, Paraguay, Bangladesh.

Send Inquiry